000 | 01172 a2200373 4500 | ||
---|---|---|---|
005 | 20250518032450.0 | ||
264 | 0 | _c20200602 | |
008 | 202006s 0 0 eng d | ||
022 | _a1474-5488 | ||
024 | 7 |
_a10.1016/S1470-2045(19)30156-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCasasnovas, René-Olivier | |
245 | 0 | 0 |
_aPET-guided, BEACOPP _h[electronic resource] |
260 |
_bThe Lancet. Oncology _c04 2019 |
||
300 |
_ae190 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aCyclophosphamide |
650 | 0 | 4 | _aHodgkin Disease |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPositron-Emission Tomography |
650 | 0 | 4 | _aProcarbazine |
650 | 0 | 4 | _aVincristine |
700 | 1 | _aBouabdallah, Reda | |
700 | 1 | _aBrice, Pauline | |
700 | 1 | _aLazarovici, Julien | |
700 | 1 | _aGhesquieres, Hervé | |
700 | 1 | _aStamatoullas, Aspasia | |
700 | 1 | _aBerriolo-Riedinger, Alina | |
700 | 1 | _aFornecker, Luc-Matthieu | |
700 | 1 | _aAndré, Marc | |
700 | 1 | _aMeignan, Michel | |
773 | 0 |
_tThe Lancet. Oncology _gvol. 20 _gno. 4 _gp. e190 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(19)30156-1 _zAvailable from publisher's website |
999 |
_c29546804 _d29546804 |